Graft-versus-host disease (GVHD) can be acute or chronic. The pathogenesis of chronic GVHD is unclear. Chronic GVHD affects mainly skin, liver and digestive tract. Intestinal involvement is uncommon and histological features are poorly described. We report here the clinical, histological and immunohistochemical features of chronic GVHD with intestinal involvement. Intestinal biopsies from children with chronic GVHD (n = 17) were compared to control children (n = 21: 10 non-transplant cases, four non-GVHD transplant cases, seven acute GVHD). We evaluated clinical outcome, histological features and characterized immunohistochemically the immune cells involved locally. Chronic GVHD with intestinal involvement was usually multisystemic (88.2%) and preceded by acute GVHD in 88.2% of cases. The outcome was severe with complete recovery in only 58.8% of cases, and death related to chronic GVHD in 17.6% of cases. Histological features were characterized by (1) villous atrophy and (2) glandular lesions, mainly apoptotic with variable intensity and (3) lamina propria infiltrate with cytotoxic T lymphocytes (CD3 + , CD8 + , TiA1 + , granzyme B − ) which were significantly (P Ͻ 0.001) increased compared to non-GVHD transplant and non-transplant controls. Therefore in chronic intestinal GVHD, the apoptotic process could be related to cytotoxic T lymphocytes.
Intestinal lesions in chronic GVHD are poorly described in the literature, primarily being described in the oesophagus. 6 The clinical presentation and endoscopic findings are non-specific and there is a broad differential diagnosis, including bacterial, fungal, viral and parasitic infections. The outcome of the disease is usually severe, especially in cases of gastrointestinal involvement, and requires an intensive immunosuppressive treatment that renders the host vulnerable to opportunistic infections. [3] [4] [5] 7, 8 For this reason, a histological confirmation of the diagnosis is recommended to avoid inappropriate treatment of patients. Whilst histological features in gastrointestinal tract are well described in acute GVHD [9] [10] [11] [12] [13] and in chronic GVHD in the esophagus, 6 this is not the case for chronic intestinal GVHD. Moreover, the immune cells involved locally at the intestinal level have been studied immunohistochemically in acute but not in chronic GVHD. [14] [15] [16] [17] [18] The aims of this study were (1) to analyze the clinical outcome of chronic intestinal GVHD after BMT in children, (2) to determine histologic features in digestive tract biopsies (gastric, small bowel and colonic) which could be considered as more specific for chronic intestinal GVHD, and (3) to characterize immunohistochemically the immune cells involved locally.
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Materials and methods
Patients
We retrospectively reviewed all the intestinal biopsies performed in children clinically suspected of having chronic intestinal GVHD (nausea, vomiting, alimentary intolerance, diarrhea) who underwent allogeneic BMT. Between January 1986 and February 1994, 232 allogenic BMT have been performed in this center.
We selected 35 intestinal biopsies with histological features consistent with GVHD from 17 patients (gastric (n = 3), duodenal (n = 18), colic (n = 7), rectal (n = 7)).
The main characteristics of the patients are summarized in Table 1 . All patients were children and pretransplant diagnosis was: severe combined immunodeficiency disease (SCID) (n = 12), Omenn's disease (n = 1), LFA-1 deficiency (n = 1), lack of HLA II expression (n = 1), Hurler's disease (n = 1) and acute lymphoblastic leukemia (n = 1).
Control groups
Three control groups were selected and explored for abdominal pain or diarrhea: (1) non-transplant specimens of histologically normal bowel (n = 10), (2) BMT recipients without clinical or histological evidence of intestinal or extra-intestinal GVHD (n = 4), (3) BMT recipients with intestinal acute GVHD (n = 7). The main characteristics of these patients are summarized in Table 2 .
Histopathologic analysis
The biopsy specimens were fixed in formalin or in Bouin's fluid and embedded in paraffin or frozen in precooled isopentane and stored at −70°C. Sections were stained with 
Frozen sections
Four m cryosections were air-dried and washed in TrisNaCl buffer at pH 7.4. The appropriate dilution of each monoclonal antibody was applied and sections were incubated for 30 min in a moist chamber. The antibodies studied characterized T cell lymphocytes: CD3 (MO835, UCHT1; Dako), CD8 (MO707, DK25; Dako), ␤F1 (8A3, TA1151; T Cell Diagnostics, Cambridge, UK), TCR ␦1 (5A6,E9, TA3061; T Cell Science, Cambridge, UK).
The following technique was identical to those described for fixed sections.
Quantification and assessment of immunohistochemical staining
Immunostaining results were expressed quantitatively. CD3-, CD8-and TiA1-positive cells were counted in surface epithelium (per 100 epithelial cells). The CD3-, CD8-, TiA1-, granzyme B-and CD68-positive cells were expressed in lamina propria as the mean percentage of mononuclear cells counted on six representative grids at ×1000 magnification. In the case of histologic lesions on the specimen, we selected two grids on areas with increased cellularity associated with epithelial lesions, two others on areas with increased cellularity without epithelial lesions and the last two on areas considered as normal or subnormal. Expression of HLA-DR by surface and glandular epithelium was also assessed quantitatively as the number of glands stained per 10 glands. Specimens were assessed by a pathologist (DR) unaware of the clinical features of the patients and the stool results, each grid was counted twice and the mean of the two counts was recorded. Nine specimens (39%), including two chronic GVHD, two acute GVHD, two non-GVHD transplant cases, and three nontransplant cases were also assessed by a second pathologist (NPM) unaware of the clinical features of the patients, the stool results and the results of the first count. We found an inter-observer correlation of 88%.
Statistical analysis
Results are reported as means ± s.e. The significance of the differences was calculated using Student's t-test. Sensitivity Bone Marrow Transplantation is defined for each histological feature (apoptosis, glandular dilatation, glandular disappearance, crypt abscesses, intraglandular epithelial necrosis) as true positive/(true positive+false negative). Specificity is defined for each of these histological features as true negative/(true negative+false positive). We determined the specificity of the histological features of chronic GVHD compared to non-transplant cases and transplant cases without GVHD.
Results
Clinical results
Seventeen patients out of 232 with allogenic BMT, clinically suspected of having chronic intestinal GVHD, developed histological features consistent with chronic intestinal GVHD. The main clinical characteristics are summarized in Table 3 . Median follow-up after BMT was 4.5 years (0.3 to 10 years) for all patients; 193 and 172 patients, respectively, were survivors at day 100 and at 1 year. Chronic GVHD was preceded by an acute phase in 15 cases (88.2%). The majority of the patients was symptomatic (88.2%). They presented essentially with diarrhea (n = 15 (88.2%)) and nausea-vomiting (n = 12 (70.6%)) with, in some cases, a complete alimentary intolerance requiring enteral or parenteral nutrition (n = 6 (35.3%)).
At the chronic stage, the intestinal tract was the sole organ affected in two cases (11.8%).
When another organ (liver, skin, lung or muscle) was suspected of being involved by GVHD on biological or clinical grounds, the diagnosis was confirmed histologically. Hepatic GVHD was represented by vanishing bile duct syndrome, skin GVHD was represented early by a lichenoid feature and later by sclerodermiform lesion. Lung GVH was characterized by lymphoid infiltration around bronchioles with lymphocyte migration into epithelium and muscle GVH by mononuclear infiltration.
Two organs were affected in six cases (35.3%), and involved the intestine with skin (n = 3), liver (n= 2) and lung (n = 1). Three organs were affected in nine cases (52.9%) and concerned the intestine with skin and liver (n = 6), skin and lung (n = 1), liver and bone marrow (n = 1), skin and muscle (n = 1). There were no significant differences between patients with one, two or three organs affected concerning duration of immunosuppressive therapy or clinical evolution of the disease. However, in the three cases where the death was related to chronic GVHD, three organs were involved. Endoscopically a severe macroscopic lesion, described as a stenosis of the oesophagus was observed in one patient who complained of dysphagia. In the other 16 cases, the intestinal mucosa was normal or slightly erythematous.
All the patients with intestinal chronic GVHD received at least one immunosuppressive treatment during the posttransplant follow-up. The duration of immunosuppressive therapy was prolonged (3.0 ± 2.2 years) and most of the patients (76.5%) required immunosuppressive therapy other than corticosteroid or cyclosporine (Table 3) .
There was a complete recession of the symptomatology in 10 cases (58.8%) and persistent minor symptoms in three cases (17.6%) consisting of diarrhea and nausea-vomiting after a follow-up of 1.3, 2.5 and 10 years; one of these three patients died during follow-up. Death was related to the relapse of the hemopathy. The outcome was severe in four cases (23.6%) leading to death in three cases and in the last case to repeated systemic infections, severe digestive and pulmonary involvement and complete alimentary intolerance requiring nutrition by a gastrostomy. Eleven out of the 17 patients presented one or more systemic infections after GVHD. Five patients had a positive CMV viremia requiring therapy with foscarnet or ganciclovir with pulmonary involvement in two cases. The other causes of infection were septicemia related to catheter infection (n = 5), BCGitis (n = 1), pulmonary and meningeal tuberculosis (n = 1), cholecystitis (n = 1), bacteremic shock related to bone marrow aplasia (n = 1), multisystemic infection related to Enterovirus (n = 1), to Klebsiella (n = 1), septicemia related to Salmonella (n = 1) and infectious pneumonia (n = 1).
Two patients presented a chronic enteric infection by Cryptosporidium parvum associated with chronic GVHD. No case of intestinal involvement by CMV was found in our study.
Histopathologic and immunopathologic results
Glandular injury: Glandular epithelial apoptosis was observed in nine biopsies of chronic GVHD (25.7% from 17 patients and 35 biopsies) of gastric, duodenal and rectal mucosa (Figures 1a,b,c,d ), five biopsies of acute GVHD (62.5% from seven patients and eight biopsies), 10 biopsies of intestinal cryptosporidiosis (90.9% from 10 patients and 11 biopsies), two biopsies of non-GVHD transplant cases (25.0% from four patients and eight biopsies) and one biopsy of non-transplant cases (10.0% from 10 patients and 10 biopsies). The intensity of epithelial apoptosis varied greatly from one biopsy to another in cases of chronic GVHD and acute GVHD (Figure 2) .
The type of glandular lesions was the same in cases of chronic GVHD as in cases of acute GVHD (Figure 3 ) but the lesions were more severe in acute GVHD. The lesions involved glandular dilatation or atrophy and epithelial cell death (apoptosis of individual epithelial cells) (Figure 1d ).
Sensitivity and specificity of each of these histological features are reported in Table 4 .
The glandular epithelial expression of HLA-DR was significantly increased in cases of chronic GVHD (Figure 1e ) and acute GVHD compared to non-GVHD transplant cases and non-transplant cases (Figure 4 ). HLA-DR was expressed by only a few glands or diffusely by the intestinal epithelium.
Lamina propria infiltrate:
A moderate fibrosis of the lamina propria was observed in only one case. There was a sparse diffuse inflammatory infiltrate focally condensed around altered glands in all 17 cases. This inflammatory infiltrate was often very moderate and correlated poorly with the severity of the disease.
The immunopathologic results are summarized in Figure 5 . In chronic and acute GVHD, there was a significant increase (P Ͻ 0.0001) of lamina propria CD3 + , CD8 + (Figure 1f ), TiA1 + (Figure 1g ) cytotoxic T lymphocytes compared to non-GVHD transplant cases and non-transplant cases. The granzyme expression was not increased in the chronic and acute GVHD groups. Two patients with chronic GVHD were also infected by Cryptosporidium parvum; the immunostaining, performed on three biopsies from these patients, showed similar results to those observed with chronic GVHD alone, with increased lamina propria CD3 + , CD8 + , TiA1 + T lymphocytes and absence of granzyme expression.
Villous atrophy: Villous atrophy was observed in 11 duodenal biopsies (61.1%) from 10 patients with chronic phenotype was observed: CD3 + , TiA1 + , predominantly CD8 − . The immunostaining performed on frozen biopsies in three of these seven duodenal biopsies (two with lack of CD8 expression by IEL) showed similar results to those a Specificity of each histological feature in the diagnosis of chronic GVH compared to non-transplant cases. b Specificity of each histological feature in the diagnosis of chronic GVH compared to transplant cases without GVH. Sensitivity is defined for each histological feature (apoptosis, glandular dilatation, glandular disappearance, crypt abscesses, intraglandular epithelial necrosis) as true positive/(true positive+false negative). Specificity is defined for each of these histological features as true negative/(true negative+false positive) observed in formalin or Bouin's fluid fixed biopsies for CD3 and CD8 expression. The IELs expressed essentially TCR␣␤ and in a few cases TCR␥␦. The two patients with severe villous atrophy and lack of expression of CD8 by CD3 + IEL had a severe clinical outcome with death related to chronic GVHD in one case and in the other case diarrhea, requiring parenteral nutrition. On the other hand, the four patients with normal CD3
+ CD8 + IEL all presented a complete disappearance of symptoms.
The abnormal CD3 + CD8 − IEL population observed in two patients was also observed in the blood at the same time, followed by normal blood cell and mucosal cell phenotype restoration.
We suggest that, contrary to refractory celiac disease, 19 this abnormal population was not a local population induced by local immunity, but reflected the slow bone marrow recovery. 
Discussion
This study, conducted in children allografted for immune deficiency, confirms that intestinal chronic GVHD is a severe disease, usually multisystemic (88.2%), preceded in the majority of cases by an acute GVHD (88.2%). Intestinal involvement is considered as uncommon in chronic GVHD, but with an unknown incidence of occurrence. [3] [4] [5] 7, 8 The present work found an incidence of 7.3% (17/232), which is probably underestimated because most of our patients were symptomatic (88.2%). With a mean follow-up of 69 ± 27 months, we noted a complete recovery in 58.8% of cases and three deaths (17.6%) were directly related to chronic GVHD. The systemic infections were frequent (64.7%), related to immunodeficiency observed in this disease. 2 Intestinal chronic GVHD histologic features could be severe, with glandular disappearance, crypt abscesses, pluri-cellular apoptosis, major inflammatory infiltrate in lamina propria; but, usually, lesions were moderate and focal. Similar lesions were found in acute GVHD, although generally were more severe. The intensity of histologic features correlated poorly with the severity of the disease.
In SCID children with enteropathy, the lesions are different, characterized by a polymorphous inflammatory infiltration and a glandular dedifferentiated epithelium, mostly related to infection. Moreover, after transplantation, the children with SCID have a normal immune reconstitution, and do not develop SCID-related enteropathy. 20 Immunostaining showed a significant increase of lamina propria cytotoxic T lymphocytes CD3 + , CD8 + , TiA1 + without granzyme B expression as compared to non-GVHD transplant cases and non-transplant cases. This inflammatory infiltrate was moderate and correlated poorly with the severity of the disease. It can be explained by the conditioning regimen for BMT that induces the low cellularity of the lamina propria. The similarity of the lamina propria inflammatory infiltrate in intestinal biopsies between chronic and acute GVHD is in agreement with the immunohistological results described in skin biopsies. [21] [22] [23] [24] Thus it suggests that the physiopathogenic mechanisms leading to acute or chronic GVHD in humans are to a large extent overlapping, contrary to those described in mice. [25] [26] [27] [28] 29 In humans, the immunohistochemical studies performed on skin biopsies from acute and chronic GVHD found comparable results with a predominant infiltrate of CD8 + T lymphocytes in the epidermis. [21] [22] [23] The emergence of an autoreactive T cell population in chronic GVHD, not observed in acute GVHD, has been shown after BMT. 30 Accumulated evidence suggests that the single most useful morphological marker of GVHD in the gastrointestinal tract is epithelial cell apoptosis. [9] [10] [11] [12] [13] The present study shows that epithelial cell apoptosis is also the main morphologic change for the diagnosis of chronic GVHD compared with normal biopsies from transplant or non-transplant cases. In our study, the main differential diagnosis with chronic GVHD was intestinal cryptosporidiosis. This result differs from previous data, in adult patients allografted for hemopathy, where CMV colitis was the main differential diagnosis. 13 Cryptosporidium parvum is easily overlooked when parasitized intestinal biopsy specimens are examined by light microscopy. However, the diagnostic problem is, when the patient who underwent BMT is infected by Cryptosporidium parvum, how to affirm or to exclude associated GVHD. Since histologic features do not allow differentiation of intestinal GVHD from cryptosporidiosis, one could use immunohistological staining. Indeed, in our experience of cryptosporidiosis without GVHD there is an increase of granzyme B expression in lamina propria, but not when cryptosporidiosis was associated with GVHD. 31 Epithelial cell apoptosis can also be induced in AIDS [32] [33] [34] or in constitutional immunodeficiency, 35 inflammatory bowel disease, 36 drug-related lesions, 37 melanosis coli, 38 radiation colitis 38 and infectious colitis. 39 Epithelial cell apoptosis in enteric biopsy after BMT is abnormal, 32 suggesting a pathologic process, but is not specific to GVHD.
The increased number of IEL, associated with villous atrophy, as in celiac disease, could be related to an autoBone Marrow Transplantation reactive T cell population and could imply a more severe outcome when this population appears to be more restricted with the emergence of a T cell CD3
+ CD8 − population, normally expressed by a few percent (Ͻ20%) of normal IEL. 40 A real correlation could not be carried out with so few cases.
The apoptotic process is probably mediated by the cytotoxic T lymphocytes CD3 + , CD8 + , TiA1 + which are significantly increased in lamina propria in the case of chronic GVHD and acute GVHD. 31, 41 In contrast, granzyme B expression was not increased in the case of acute and chronic GVHD. This result is in agreement with previous work showing no perforin expression in chronic GVHD skin biopsies but keratinocyte membrane expression of Fas. 28 The apoptotic process can be mediated in chronic GVHD by Fas/FasLigand that is known to be, with the granzyme/perforin system, the pathway preferentially used by CD8
+ T cells to induce cell apoptosis. 42 In conclusion, T lymphocytes seem to play a major role in the constitution of histologic features in chronic intestinal GVHD by direct cytotoxicity, probably with other cells such as the enterocytes via the Fas/Fas ligand pathway.
